IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 394 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,616,047 | +7.2% | 57,673 | -3.1% | 0.00% | 0.0% |
| Q2 2023 | $2,441,121 | +27.1% | 59,496 | +10.7% | 0.00% | +50.0% |
| Q1 2023 | $1,920,382 | -27.7% | 53,732 | -23.5% | 0.00% | -50.0% |
| Q4 2022 | $2,654,362 | -14.6% | 70,277 | +0.0% | 0.00% | 0.0% |
| Q3 2022 | $3,108,263 | +48.4% | 70,275 | +24.3% | 0.00% | -20.0% |
| Q2 2022 | $2,094,000 | -12.0% | 56,555 | -12.0% | 0.01% | 0.0% |
| Q1 2022 | $2,380,000 | +19.4% | 64,265 | -1.9% | 0.01% | +25.0% |
| Q4 2021 | $1,993,000 | +39.2% | 65,508 | +53.4% | 0.00% | +33.3% |
| Q3 2021 | $1,432,000 | -17.3% | 42,700 | -1.7% | 0.00% | 0.0% |
| Q2 2021 | $1,732,000 | +25.4% | 43,419 | +41.4% | 0.00% | 0.0% |
| Q1 2021 | $1,381,000 | -24.8% | 30,711 | -5.5% | 0.00% | -25.0% |
| Q4 2020 | $1,837,000 | +12.9% | 32,484 | -5.3% | 0.00% | 0.0% |
| Q3 2020 | $1,627,000 | -22.4% | 34,288 | -3.6% | 0.00% | -20.0% |
| Q2 2020 | $2,098,000 | -3.0% | 35,582 | -22.2% | 0.01% | -16.7% |
| Q1 2020 | $2,163,000 | -24.6% | 45,756 | -3.6% | 0.01% | 0.0% |
| Q4 2019 | $2,869,000 | -24.9% | 47,484 | -25.5% | 0.01% | -25.0% |
| Q3 2019 | $3,818,000 | -9.2% | 63,730 | -2.6% | 0.01% | -11.1% |
| Q2 2019 | $4,204,000 | -23.8% | 65,415 | -3.7% | 0.01% | -25.0% |
| Q1 2019 | $5,516,000 | +36.0% | 67,952 | -9.4% | 0.01% | +20.0% |
| Q4 2018 | $4,055,000 | -10.6% | 75,018 | -14.7% | 0.01% | +11.1% |
| Q3 2018 | $4,538,000 | +28.2% | 87,997 | +3.5% | 0.01% | +12.5% |
| Q2 2018 | $3,541,000 | +8.2% | 84,982 | +14.4% | 0.01% | +14.3% |
| Q1 2018 | $3,274,000 | +43.9% | 74,282 | +64.2% | 0.01% | +40.0% |
| Q4 2017 | $2,275,000 | -4.7% | 45,225 | -3.9% | 0.01% | 0.0% |
| Q3 2017 | $2,386,000 | -1.7% | 47,064 | -1.4% | 0.01% | 0.0% |
| Q2 2017 | $2,428,000 | +24.0% | 47,737 | -2.0% | 0.01% | +25.0% |
| Q1 2017 | $1,958,000 | -19.9% | 48,710 | -4.7% | 0.00% | -33.3% |
| Q4 2016 | $2,445,000 | +23.5% | 51,115 | -5.4% | 0.01% | +50.0% |
| Q3 2016 | $1,980,000 | +61.2% | 54,043 | +2.5% | 0.00% | +33.3% |
| Q2 2016 | $1,228,000 | -41.7% | 52,713 | +1.3% | 0.00% | -40.0% |
| Q1 2016 | $2,108,000 | -36.1% | 52,051 | -2.2% | 0.01% | -37.5% |
| Q4 2015 | $3,297,000 | – | 53,234 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |